Browsing Tag
Citigroup
25 posts
Intertek Group (LON: ITRK) surges 12% as demerger plan reshapes the investment case
Intertek Group (LON: ITRK) surged 12% on 14 April 2026 after launching a strategic review to split into two businesses. Q1 revenue hit £838.5m. Full retail investor analysis here.
Why Blackstone Digital Infrastructure Trust’s IPO filing matters for Blackstone Inc. (NYSE: BX) and data center investors
Blackstone Digital Infrastructure Trust has filed for an IPO. Read why this BXDC move matters for Blackstone, hyperscalers, and AI data center investors.
Supermicro (SMCI): Can the AI server giant survive its legal crisis and deliver on $36bn guidance?
Supermicro (SMCI) trades near USD 22 after the DOJ indicted its co-founder for alleged Nvidia chip smuggling. Here is what retail investors need to know before the May 5 earnings report.
Why ING Groep (INGA) ending its Russia sale matters beyond one failed bank disposal
ING has scrapped the sale of its Russian bank after approval delays. Read what this means for capital, strategy, and Europe’s broader Russia exit playbook.
Unilever to combine Foods business with McCormick in $44.8bn deal to create global flavour powerhouse
Unilever to sell its $44.8bn Foods business to McCormick in a Reverse Morris Trust deal. Read what this means for ULVR shareholders and MKC's leverage.
Inside Galderma’s €500m bond deal and what it reveals about the dermatology market’s financial momentum
Galderma raises €500M via a five-year eurobond to refinance IPO debt and strengthen its balance sheet. Discover what this means for GALD investors.
A $560m test for the diabetes device market as MiniMed prepares to trade on Nasdaq
MiniMed prices its IPO at $20 per share, raising $560M as Medtronic plc spins out its diabetes unit. Discover what the move means for the diabetes technology market.
Warner Bros. Discovery (WBD) shareholders to receive $31 per share as Paramount Skydance (PSKY) tables $110bn bid
Paramount Skydance to acquire Warner Bros. Discovery for $110B, merging HBO Max, Paramount+, and two major studios. What it means for streaming rivals and investors. Read more.
Ribo Life Science raises HKD1.8bn in Hong Kong IPO amid strong institutional support for siRNA growth strategy
Ribo Life Science’s HKEX IPO raised HKD 1.83B for siRNA drug development. See how it could reshape RNA biotech investment trends in Asia. Read more.
Karbon Capital Partners raises $345m in SPAC IPO with energy-AI strategy in focus
Karbon Capital’s $345M SPAC IPO targets energy infrastructure deals tied to AI and LNG growth. Find out what this means for investors and industry players.